| Primary |
| Hypertension |
40.9% |
| Drug Use For Unknown Indication |
24.5% |
| Diabetes Mellitus |
9.5% |
| Product Used For Unknown Indication |
4.9% |
| Essential Hypertension |
3.7% |
| Depression |
3.5% |
| Cardiac Failure |
2.0% |
| Drug Exposure During Pregnancy |
1.4% |
| Analgesic Therapy |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Blood Pressure |
0.9% |
| Cardiac Failure Congestive |
0.9% |
| Hypertonia |
0.9% |
| Myalgia |
0.9% |
| Sleep Disorder |
0.9% |
| Arthralgia |
0.6% |
| Atrial Fibrillation |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Coronary Artery Disease |
0.6% |
| Insomnia |
0.6% |
|
| Pulmonary Embolism |
9.1% |
| Syncope |
9.1% |
| Intraocular Pressure Test Abnormal |
6.1% |
| Stillbirth |
6.1% |
| Caesarean Section |
4.5% |
| Fall |
4.5% |
| Femur Fracture |
4.5% |
| Hip Fracture |
4.5% |
| Hypertension |
4.5% |
| Intestinal Obstruction |
4.5% |
| Mitral Valve Incompetence |
4.5% |
| Oral Pain |
4.5% |
| Pharyngitis |
4.5% |
| Prostate Cancer Metastatic |
4.5% |
| Renal Failure |
4.5% |
| Road Traffic Accident |
4.5% |
| Treatment Noncompliance |
4.5% |
| Vocal Cord Paralysis |
4.5% |
| Acute Psychosis |
3.0% |
| Bradycardia |
3.0% |
|
| Secondary |
| Hypertension |
41.0% |
| Diabetes Mellitus |
18.0% |
| Drug Use For Unknown Indication |
10.0% |
| Cardiac Failure |
6.0% |
| Rheumatoid Arthritis |
5.0% |
| Essential Hypertension |
4.0% |
| Cardiomyopathy |
3.0% |
| Oedema |
2.0% |
| Product Used For Unknown Indication |
2.0% |
| Prophylaxis |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Blood Pressure |
1.0% |
| Depression |
1.0% |
| Sciatica |
1.0% |
| Sleep Disorder |
1.0% |
| Systemic Antibacterial Therapy |
1.0% |
|
| Bradycardia |
12.5% |
| Pharyngitis |
9.4% |
| Throat Tightness |
9.4% |
| Unevaluable Event |
9.4% |
| Fall |
6.3% |
| Hypertension |
6.3% |
| Intestinal Obstruction |
6.3% |
| Pregnancy |
6.3% |
| Skull Malformation |
6.3% |
| Drug Interaction |
3.1% |
| Fungal Infection |
3.1% |
| Oral Pain |
3.1% |
| Panic Reaction |
3.1% |
| Pharyngeal Oedema |
3.1% |
| Renal Failure |
3.1% |
| Respiratory Tract Infection |
3.1% |
| Swelling Face |
3.1% |
| Weight Decreased |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.6% |
| Hypertension |
15.9% |
| Depression |
8.5% |
| Pain |
7.7% |
| Rheumatoid Arthritis |
6.9% |
| Diabetes Mellitus |
4.5% |
| Unevaluable Event |
3.5% |
| Emphysema |
3.3% |
| Pain Management |
3.3% |
| Urinary Tract Infection |
3.1% |
| Osteoporosis |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Asthma |
2.2% |
| B-cell Lymphoma |
2.0% |
| Colon Cancer |
2.0% |
| Infection |
2.0% |
| Blood Cholesterol Increased |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Arthritis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
|
| Weight Decreased |
19.5% |
| Weight Increased |
9.2% |
| Vomiting |
8.0% |
| Syncope |
6.9% |
| Wound Drainage |
5.7% |
| Deep Vein Thrombosis |
4.6% |
| Hypokalaemia |
4.6% |
| Contusion |
3.4% |
| Cytomegalovirus Enteritis |
3.4% |
| Death |
3.4% |
| Haemorrhage Intracranial |
3.4% |
| Hypersensitivity |
3.4% |
| Lung Infection |
3.4% |
| Neuropathic Arthropathy |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Vertigo |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Anal Fissure |
2.3% |
| Breast Cancer Female |
2.3% |
| Cardiac Failure Congestive |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
